News | AseBio - Asociación Empresas Biotecnología

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine

Médico consultando datos de un paciente en una tablet

International Clinical Trials Day: Driving healthcare innovation through Artificial Intelligence

Healthcare · Access to innovation · Digitalization

The TerminAI project aims to optimize healthcare data management through artificial intelligence,…

Prevención versus Terapia. El gran avance del siglo actual

Prevention versus Therapy. The breakthrough of the current century

Massive data collection accelerated by the digitisation of healthcare, as well as artificial…

Patricia Ortega Muñoz

#NewAseBioMember | “AseBio is the meeting point for all companies that aim to contribute to science through the biotechnology sector”

Healthcare · Corporate

Meet our new member MedBioinformatics. We sponke with Patricia Ortega Muñoz, CEO and Medical…

Conferencia Anual Plataformas Tecnológicas Investigación Biomédica

Biomedical innovation 'made in Spain': Challenges and opportunities in the long race to market

Healthcare · Access to innovation · Financing

Experts from the sector highlighted at the 18th Annual Conference of the Biomedical Research…

Científicos analizando muestras en un laboratorio

Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01 with Gemcitabine/nab-Paclitaxel in Newly-Diagnosed Metastatic Pancreatic Cancer Patients

Healthcare · Access to innovation · Innovative drugs

Patients treated with VCN-01 (zabilugene almadenorepvec) plus gemcitabine/nab-paclitaxel standard-…

Edificio Oryzon

ORYZON awarded 13.26 million € through the first Important Project of Common European Interest (IPCEI) in the health sector (Med4Cure project)

Healthcare · Rare diseases · Innovative drugs

Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and…

Oficinas de la compañía biotech Natac

Natac closes 2024 with record sales of nearly 36 million euros

The company increased its normalized EBITDA by 47%, reaching €13.82 million.

CEOs de las empresas Nuage Therapeutics, Ona Therapeutics y SpliceBio

Nuage Therapeutics, Ona Therapeutics, and SpliceBio are leading the wave of biotech innovation in Barcelona

Healthcare · Rare diseases · Personalized medicine · Advanced therapies

Las biotecnológicas Nuage Therapeutics, Ona Therapeutics y SpliceBio, con sede en el Parque…

#NewAseBioMember | "We believe that AseBio can serve as an important tool for expanding collaborations"

Healthcare · Corporate

Meet our new member MedBioinformatics. We sponke with Ferran Sanz, Founding Partner, Member of the…